The Profile of Lung Adenocarcinoma Patients With Positive EGFR Mutation

Green Medical Journal
doi 10.33096/gmj.v2i1.37
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Universitas Muslim Indonesia

Related search

Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing

Oncologist
Cancer ResearchMedicineOncology
2019English

Relationship Between EGFR Mutation and Computed Tomography Characteristics of the Lung in Patients With Lung Adenocarcinoma

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2018English

Presence of the Minor EGFR T790M Mutation Is Associated With Drug-Sensitive EGFR Mutations in Lung Adenocarcinoma Patients

Oncology Reports
MedicineCancer ResearchOncology
2014English

Different Mutational Characteristics of the Subsets of EGFR-tyrosine Kinase Inhibitor Sensitizing Mutation-Positive Lung Adenocarcinoma

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma With EGFR Mutation

Clinical Cancer Research
Cancer ResearchOncology
2014English

P1.13-12 EGFR Therapy in ASCL1 Positive Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.13-24 Efficacy of EGFR-TKIs Compared With Chemotherapy as First-Line Therapy in Patients With EGFR Rare Mutation Advanced Lung Adenocarcinoma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Real-World Experience of Afatinib as a First-Line Therapy for Advanced EGFR Mutation-Positive Lung Adenocarcinoma

Oncotarget
Oncology
2017English

EGFR Mutation in Patients With Lung Adenosquamous Cell Carcinoma

Annals of Surgical Oncology
OncologySurgery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy